wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50052465-38D5D994-607F-4C5B-B851-135B655669AF
Q50052465-38D5D994-607F-4C5B-B851-135B655669AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50052465-38D5D994-607F-4C5B-B851-135B655669AF
More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes.
P2860
Q50052465-38D5D994-607F-4C5B-B851-135B655669AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50052465-38D5D994-607F-4C5B-B851-135B655669AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c5a8b6c62086fed0d5d6d79b9f7191064b6d8fb
P2860
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate n